Calidi Biotherapeutics CLDI
NYSE CLDI
$0.68 -0.02 (-2.86%)
At close: Nov 11, 2026 · 4:00 PM EST

Calidi Biotherapeutics (CLDI) Net Preferred Shares Issued and Repurchased (2023)

Updated

Calidi Biotherapeutics (CLDI) recorded Net Preferred Shares Issued and Repurchased of $14.91 million in FY2023, compared with $195,000 in FY2022.

Analysis

Calidi Biotherapeutics (CLDI) Net Preferred Shares Issued and Repurchased (2023) Analysis & Trends

  • Per Business Quant data, CLDI's Net Preferred Shares Issued and Repurchased was $195,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Calidi Biotherapeutics 991,199.98 -25.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 166,000.00
API Access

Calidi Biotherapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CLDI&period=max&api_key=YOUR_API_KEY